$AUXL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AUXILIUM PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AUXILIUM PHARMACEUTICALS INC. Get notifications about new insider transactions in AUXILIUM PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 7 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 12 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Buy | M | 7.81 | 5,275 | 41,198 | 18,928 | 13.7 K to 18.9 K (+38.64 %) |
Jul 05 2011 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 19.60 | 142 | 2,783 | 1,327 | 1.2 K to 1.3 K (+11.98 %) |
Jul 05 2011 | AUXL | AUXILIUM PHARMACEU ... | Lurker Nancy | Director | Grant | A | 19.60 | 95 | 1,862 | 95 | 0 to 95 |
Jul 05 2011 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 19.60 | 318 | 6,233 | 1,154 | 836 to 1.2 K (+38.04 %) |
Jul 05 2011 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 19.60 | 248 | 4,861 | 4,716 | 4.5 K to 4.7 K (+5.55 %) |
Jul 05 2011 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 19.60 | 354 | 6,938 | 8,965 | 8.6 K to 9 K (+4.11 %) |
Jul 05 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | J | 0.00 | 6,992 | 0 | 6,112,357 | 6.1 M to 6.1 M (+0.11 %) |
Jul 05 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 6,992 | 0 | 0 | 7 K to 0 (-100.00 %) |
Jun 20 2011 | AUXL | AUXILIUM PHARMACEU ... | Lurker Nancy | Director | Option Exercise | A | 19.78 | 15,000 | 296,700 | 15,000 | |
Jun 20 2011 | AUXL | AUXILIUM PHARMACEU ... | MCKEE WILLIAM | Director | Option Exercise | A | 19.78 | 15,000 | 296,700 | 15,000 | |
Jun 20 2011 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Option Exercise | A | 19.78 | 15,000 | 296,700 | 15,000 | |
Jun 20 2011 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 19.78 | 15,000 | 296,700 | 15,000 | |
Jun 20 2011 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Option Exercise | A | 19.78 | 15,000 | 296,700 | 15,000 | |
Jun 20 2011 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Option Exercise | A | 19.78 | 25,000 | 494,500 | 25,000 | |
Jun 20 2011 | AUXL | AUXILIUM PHARMACEU ... | Brandt Peter C. | Director | Option Exercise | A | 19.78 | 15,000 | 296,700 | 15,000 | |
Jun 20 2011 | AUXL | AUXILIUM PHARMACEU ... | ALTOMARI ALFRED | Director | Option Exercise | A | 19.78 | 15,000 | 296,700 | 15,000 | |
May 25 2011 | AUXL | AUXILIUM PHARMACEU ... | Chambon Philippe O. | Director | Sell | J | 21.77 | 21,726 | 472,953 | 7,554 | 29.3 K to 7.6 K (-74.20 %) |
May 13 2011 | AUXL | AUXILIUM PHARMACEU ... | Chambon Philippe O. | Director | Sell | J | 23.00 | 718,858 | 16,533,734 | 29,280 | 748.1 K to 29.3 K (-96.09 %) |
Apr 04 2011 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Payment of Exercise | F | 22.47 | 941 | 21,144 | 16,878 | 17.8 K to 16.9 K (-5.28 %) |
Apr 04 2011 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | EVP, Sales & Market ... | Payment of Exercise | F | 22.26 | 1,806 | 40,202 | 17,619 | 19.4 K to 17.6 K (-9.30 %) |
Apr 04 2011 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | EVP, Sales & Market ... | Payment of Exercise | F | 22.47 | 941 | 21,144 | 19,425 | 20.4 K to 19.4 K (-4.62 %) |
Apr 04 2011 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Payment of Exercise | F | 22.47 | 941 | 21,144 | 25,247 | 26.2 K to 25.2 K (-3.59 %) |
Apr 04 2011 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 21.47 | 261 | 5,604 | 1,316 | 1.1 K to 1.3 K (+24.74 %) |
Apr 04 2011 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 21.47 | 145 | 3,113 | 691 | 546 to 691 (+26.56 %) |
Apr 04 2011 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 21.47 | 226 | 4,852 | 4,468 | 4.2 K to 4.5 K (+5.33 %) |
Apr 04 2011 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 21.47 | 1,164 | 24,991 | 9,485 | 8.3 K to 9.5 K (+13.99 %) |
Apr 04 2011 | AUXL | AUXILIUM PHARMACEU ... | Chambon Philippe O. | Director | Grant | A | 21.47 | 174 | 3,736 | 747,615 | 747.4 K to 747.6 K (+0.02 %) |
Mar 31 2011 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 21.98 | 3,911 | 85,963 | 149,968 | 146.1 K to 150 K (+2.68 %) |
Mar 31 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 21.98 | 309 | 6,792 | 6,992 | 6.7 K to 7 K (+4.62 %) |
Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 22.81 | 1,612 | 36,774 | 146,057 | 144.4 K to 146.1 K (+1.12 %) |
Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 22.51 | 54 | 1,215 | 144,445 | 144.4 K to 144.4 K (+0.04 %) |
Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 22.86 | 1,343 | 30,701 | 144,391 | 143 K to 144.4 K (+0.94 %) |
Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 22.88 | 2,380 | 54,449 | 143,048 | 140.7 K to 143 K (+1.69 %) |
Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 23.05 | 304 | 7,008 | 140,668 | 140.4 K to 140.7 K (+0.22 %) |
Mar 31 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 21.94 | 82,000 | 1,798,670 | 6,105,365 | 6 M to 6.1 M (+1.36 %) |
Mar 31 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.00 | 250,000 | 5,499,400 | 6,023,365 | 5.8 M to 6 M (+4.33 %) |
Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.75 | 550,000 | 12,513,765 | 5,773,365 | 5.2 M to 5.8 M (+10.53 %) |
Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 23.44 | 115,000 | 2,695,060 | 5,223,365 | 5.1 M to 5.2 M (+2.25 %) |
Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 23.17 | 117,273 | 2,717,344 | 5,108,365 | 5 M to 5.1 M (+2.35 %) |
Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.81 | 58,388 | 1,331,976 | 4,991,092 | 4.9 M to 5 M (+1.18 %) |
Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.51 | 1,948 | 43,845 | 4,932,704 | 4.9 M to 4.9 M (+0.04 %) |
Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.86 | 48,657 | 1,112,299 | 4,930,756 | 4.9 M to 4.9 M (+1.00 %) |
Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.88 | 86,227 | 1,972,693 | 4,882,099 | 4.8 M to 4.9 M (+1.80 %) |
Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 23.05 | 10,996 | 253,503 | 4,795,872 | 4.8 M to 4.8 M (+0.23 %) |
Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Sell | J | 22.76 | 718,858 | 16,361,208 | 747,441 | 1.5 M to 747.4 K (-49.03 %) |
Mar 09 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Option Exercise | M | 7.81 | 10,555 | 82,435 | 388,890 | |
Mar 09 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Sell | S | 23.03 | 5,275 | 121,502 | 16,072 | 21.3 K to 16.1 K (-24.71 %) |
Mar 09 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Buy | M | 7.81 | 5,275 | 41,198 | 21,347 | 16.1 K to 21.3 K (+32.82 %) |
Mar 09 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Sell | S | 23.01 | 5,280 | 121,492 | 16,072 | 21.4 K to 16.1 K (-24.73 %) |
Mar 09 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Buy | M | 7.81 | 5,280 | 41,237 | 21,352 | 16.1 K to 21.4 K (+32.85 %) |
Feb 22 2011 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | A | 22.04 | 40,000 | 881,600 | 40,000 | |
Feb 22 2011 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | A | 22.04 | 40,000 | 881,600 | 40,000 | |
Feb 22 2011 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | EVP, Sales & Market ... | Option Exercise | A | 22.04 | 30,000 | 661,200 | 30,000 | |
Feb 22 2011 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | A | 22.04 | 30,000 | 661,200 | 30,000 | |
Feb 22 2011 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 22.04 | 40,000 | 881,600 | 40,000 | |
Feb 22 2011 | AUXL | AUXILIUM PHARMACEU ... | ARCURI EDWARD J | EVP, Technical Oper ... | Option Exercise | A | 22.04 | 40,000 | 881,600 | 40,000 | |
Feb 22 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Option Exercise | A | 22.04 | 100,000 | 2,204,000 | 100,000 | |
Jan 12 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Option Exercise | M | 7.81 | 10,555 | 82,435 | 399,445 | |
Jan 12 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Sell | S | 23.27 | 5,275 | 122,723 | 16,072 | 21.3 K to 16.1 K (-24.71 %) |
Jan 12 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Buy | M | 7.81 | 5,275 | 41,198 | 21,347 | 16.1 K to 21.3 K (+32.82 %) |
Jan 12 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Sell | S | 23.17 | 5,280 | 122,327 | 16,072 | 21.4 K to 16.1 K (-24.73 %) |
Jan 12 2011 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Buy | M | 7.81 | 5,280 | 41,237 | 21,352 | 16.1 K to 21.4 K (+32.85 %) |
Jan 04 2011 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 21.10 | 118 | 2,490 | 1,055 | 937 to 1.1 K (+12.59 %) |
Jan 04 2011 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 21.10 | 295 | 6,225 | 546 | 251 to 546 (+117.53 %) |
Jan 04 2011 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Grant | A | 21.10 | 709 | 14,960 | 6,857 | 6.1 K to 6.9 K (+11.53 %) |
Jan 04 2011 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 21.10 | 384 | 8,102 | 4,242 | 3.9 K to 4.2 K (+9.95 %) |
Jan 04 2011 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 21.10 | 296 | 6,246 | 8,321 | 8 K to 8.3 K (+3.69 %) |
Dec 20 2010 | AUXL | AUXILIUM PHARMACEU ... | Brandt Peter C. | Director | Option Exercise | A | 21.49 | 15,000 | 322,350 | 15,000 | |
Oct 26 2010 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | A | 25.90 | 75,000 | 1,942,500 | 75,000 | |
Oct 26 2010 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Grant | A | 25.90 | 10,000 | 259,000 | 10,000 | 0 to 10 K |
Oct 04 2010 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 24.78 | 100 | 2,478 | 937 | 837 to 937 (+11.95 %) |
Oct 04 2010 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Grant | A | 24.78 | 251 | 6,220 | 251 | 0 to 251 |
Oct 04 2010 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 24.78 | 327 | 8,103 | 3,858 | 3.5 K to 3.9 K (+9.26 %) |
Oct 04 2010 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 24.78 | 252 | 6,245 | 8,025 | 7.8 K to 8 K (+3.24 %) |
Oct 04 2010 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Grant | A | 24.78 | 604 | 14,967 | 6,148 | 5.5 K to 6.1 K (+10.89 %) |
Aug 30 2010 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 25.77 | 235 | 6,056 | 140,364 | 140.1 K to 140.4 K (+0.17 %) |
Aug 30 2010 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 25.84 | 729 | 18,835 | 140,129 | 139.4 K to 140.1 K (+0.52 %) |
Aug 30 2010 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 25.34 | 851 | 21,564 | 139,400 | 138.5 K to 139.4 K (+0.61 %) |
Aug 30 2010 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 25.37 | 1,237 | 31,387 | 138,549 | 137.3 K to 138.5 K (+0.90 %) |
Aug 30 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 25.77 | 8,505 | 219,188 | 4,784,876 | 4.8 M to 4.8 M (+0.18 %) |
Aug 30 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 25.84 | 26,394 | 681,952 | 4,776,371 | 4.7 M to 4.8 M (+0.56 %) |
Aug 30 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 25.34 | 30,822 | 781,026 | 4,749,977 | 4.7 M to 4.7 M (+0.65 %) |
Aug 30 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 25.37 | 44,826 | 1,137,388 | 4,719,155 | 4.7 M to 4.7 M (+0.96 %) |
Aug 02 2010 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Gift | G | 0.00 | 53,537 | 0 | 53,537 | 0 to 53.5 K |
Aug 02 2010 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Gift | G | 0.00 | 53,537 | 0 | 16,072 | 69.6 K to 16.1 K (-76.91 %) |
Jul 28 2010 | AUXL | AUXILIUM PHARMACEU ... | ARCURI EDWARD J | EVP, Technical Oper ... | Option Exercise | A | 22.54 | 70,000 | 1,577,800 | 70,000 | |
Jul 20 2010 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Payment of Exercise | F | 22.22 | 32,080 | 712,818 | 69,609 | 101.7 K to 69.6 K (-31.55 %) |
Jul 02 2010 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 23.50 | 106 | 2,491 | 837 | 731 to 837 (+14.50 %) |
Jul 02 2010 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 23.50 | 344 | 8,084 | 3,531 | 3.2 K to 3.5 K (+10.79 %) |
Jul 02 2010 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 23.50 | 297 | 6,980 | 7,773 | 7.5 K to 7.8 K (+3.97 %) |
Jul 02 2010 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Grant | A | 23.50 | 765 | 17,978 | 5,544 | 4.8 K to 5.5 K (+16.01 %) |
Jun 07 2010 | AUXL | AUXILIUM PHARMACEU ... | MCKEE WILLIAM | Director | Option Exercise | A | 29.72 | 15,000 | 445,800 | 15,000 | |
Jun 07 2010 | AUXL | AUXILIUM PHARMACEU ... | LANGER DENNIS | Director | Option Exercise | A | 29.72 | 5,000 | 148,600 | 5,000 | |
Jun 07 2010 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Option Exercise | A | 29.72 | 15,000 | 445,800 | 15,000 | |
Jun 07 2010 | AUXL | AUXILIUM PHARMACEU ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 29.72 | 15,000 | 445,800 | 15,000 | |
Jun 07 2010 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Option Exercise | A | 29.72 | 15,000 | 445,800 | 15,000 | |
Jun 07 2010 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Option Exercise | A | 29.72 | 25,000 | 743,000 | 25,000 | |
Jun 07 2010 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Option Exercise | A | 29.72 | 15,000 | 445,800 | 15,000 | |
Jun 07 2010 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Option Exercise | A | 29.72 | 15,000 | 445,800 | 15,000 | |
Jun 07 2010 | AUXL | AUXILIUM PHARMACEU ... | ALTOMARI ALFRED | Director | Option Exercise | A | 29.72 | 15,000 | 445,800 | 15,000 | |
Jun 01 2010 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Option Exercise | M | 5.50 | 5,000 | 27,500 | 0 | |
Jun 01 2010 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Option Exercise | M | 4.15 | 3,750 | 15,563 | 0 | |
Jun 01 2010 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Option Exercise | M | 7.50 | 10,000 | 75,000 | 0 | |
Jun 01 2010 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Buy | M | 5.50 | 5,000 | 27,500 | 18,750 | 13.8 K to 18.8 K (+36.36 %) |
Jun 01 2010 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Buy | M | 4.15 | 3,750 | 15,563 | 13,750 | 10 K to 13.8 K (+37.50 %) |
Jun 01 2010 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Buy | M | 7.50 | 10,000 | 75,000 | 10,000 | 0 to 10 K |
Apr 28 2010 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | M | 5.50 | 7,318 | 40,249 | 12,682 | |
Apr 28 2010 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Sell | S | 35.67 | 7,318 | 261,061 | 4,299 | 11.6 K to 4.3 K (-62.99 %) |
Apr 28 2010 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Buy | M | 5.50 | 7,318 | 40,249 | 11,617 | 4.3 K to 11.6 K (+170.23 %) |
Apr 21 2010 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Option Exercise | M | 4.15 | 6,250 | 25,938 | 3,750 | |
Apr 21 2010 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Sell | S | 36.58 | 3,250 | 118,890 | 0 | 3.3 K to 0 (-100.00 %) |
Apr 21 2010 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Sell | S | 36.37 | 3,000 | 109,118 | 3,250 | 6.3 K to 3.3 K (-48.00 %) |
Apr 21 2010 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Buy | M | 4.15 | 6,250 | 25,938 | 6,250 | 0 to 6.3 K |
Apr 14 2010 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Payment of Exercise | F | 31.73 | 903 | 28,652 | 20,366 | 21.3 K to 20.4 K (-4.25 %) |
Apr 14 2010 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Option Exercise | M | 7.81 | 30,000 | 234,300 | 410,000 | |
Apr 14 2010 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Sell | S | 33.07 | 30,000 | 992,115 | 101,689 | 131.7 K to 101.7 K (-22.78 %) |
Apr 14 2010 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Buy | M | 7.81 | 30,000 | 234,300 | 131,689 | 101.7 K to 131.7 K (+29.50 %) |
Apr 02 2010 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 31.16 | 80 | 2,493 | 731 | 651 to 731 (+12.29 %) |
Apr 02 2010 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 31.16 | 260 | 8,102 | 3,187 | 2.9 K to 3.2 K (+8.88 %) |
Apr 02 2010 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Grant | A | 31.16 | 480 | 14,957 | 4,779 | 4.3 K to 4.8 K (+11.17 %) |
Apr 02 2010 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 31.16 | 200 | 6,232 | 7,476 | 7.3 K to 7.5 K (+2.75 %) |
Mar 16 2010 | AUXL | AUXILIUM PHARMACEU ... | DelConte Anthony | Chief Medical Offic ... | Payment of Exercise | F | 30.20 | 941 | 28,418 | 9,711 | 10.7 K to 9.7 K (-8.83 %) |
Mar 16 2010 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Payment of Exercise | F | 30.20 | 941 | 28,418 | 21,269 | 22.2 K to 21.3 K (-4.24 %) |
Mar 16 2010 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Payment of Exercise | F | 30.20 | 941 | 28,418 | 17,819 | 18.8 K to 17.8 K (-5.02 %) |
Mar 16 2010 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Payment of Exercise | F | 30.20 | 941 | 28,418 | 26,188 | 27.1 K to 26.2 K (-3.47 %) |
Mar 16 2010 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Payment of Exercise | F | 30.20 | 2,419 | 73,054 | 101,689 | 104.1 K to 101.7 K (-2.32 %) |
Mar 11 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 34.10 | 15,367 | 524,050 | 4,674,329 | 4.7 M to 4.7 M (+0.33 %) |
Mar 11 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 33.19 | 43,597 | 1,446,862 | 4,658,962 | 4.6 M to 4.7 M (+0.94 %) |
Mar 11 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 31.59 | 11,580 | 365,848 | 4,615,365 | 4.6 M to 4.6 M (+0.25 %) |
Mar 11 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 31.70 | 59,751 | 1,893,874 | 4,603,785 | 4.5 M to 4.6 M (+1.31 %) |
Mar 11 2010 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 34.10 | 1,805 | 61,555 | 137,312 | 135.5 K to 137.3 K (+1.33 %) |
Mar 11 2010 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 33.19 | 1,203 | 39,924 | 135,507 | 134.3 K to 135.5 K (+0.90 %) |
Mar 11 2010 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 31.59 | 320 | 10,110 | 134,304 | 134 K to 134.3 K (+0.24 %) |
Mar 11 2010 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 31.70 | 1,649 | 52,267 | 133,984 | 132.3 K to 134 K (+1.25 %) |
Mar 02 2010 | AUXL | AUXILIUM PHARMACEU ... | DEL TITO BENJAMIN J JR | EVP, Reg Affairs & ... | Option Exercise | A | 30.20 | 10,000 | 302,000 | 10,000 | |
Mar 02 2010 | AUXL | AUXILIUM PHARMACEU ... | DelConte Anthony | Chief Medical Offic ... | Option Exercise | A | 30.20 | 25,000 | 755,000 | 25,000 | |
Mar 02 2010 | AUXL | AUXILIUM PHARMACEU ... | DelConte Anthony | Chief Medical Offic ... | Grant | A | 0.00 | 9,378 | 0 | 10,652 | 1.3 K to 10.7 K (+736.11 %) |
Mar 02 2010 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | A | 30.20 | 35,000 | 1,057,000 | 35,000 | |
Mar 02 2010 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Grant | A | 0.00 | 9,378 | 0 | 18,760 | 9.4 K to 18.8 K (+99.96 %) |
Mar 02 2010 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Option Exercise | A | 30.20 | 35,000 | 1,057,000 | 35,000 | |
Mar 02 2010 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Grant | A | 0.00 | 9,378 | 0 | 22,210 | 12.8 K to 22.2 K (+73.08 %) |
Mar 02 2010 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Option Exercise | A | 30.20 | 150,000 | 4,530,000 | 150,000 | |
Mar 02 2010 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Grant | A | 0.00 | 24,108 | 0 | 104,108 | 80 K to 104.1 K (+30.14 %) |
Mar 02 2010 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 30.20 | 35,000 | 1,057,000 | 35,000 | |
Mar 02 2010 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Grant | A | 0.00 | 9,378 | 0 | 27,129 | 17.8 K to 27.1 K (+52.83 %) |
Jan 29 2010 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Gift | G | 0.00 | 3,000 | 0 | 0 | 3 K to 0 (-100.00 %) |
Jan 05 2010 | AUXL | AUXILIUM PHARMACEU ... | LANGER DENNIS | Director | Grant | A | 29.98 | 333 | 9,983 | 1,366 | 1 K to 1.4 K (+32.24 %) |
Jan 05 2010 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 29.98 | 325 | 9,744 | 2,927 | 2.6 K to 2.9 K (+12.49 %) |
Jan 05 2010 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 29.98 | 20 | 600 | 651 | 631 to 651 (+3.17 %) |
Jan 05 2010 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Grant | A | 29.98 | 499 | 14,960 | 4,299 | 3.8 K to 4.3 K (+13.13 %) |